Advertisement
Loading...

Idorsia Ltd

IDRSF•PNK
Healthcare
Biotechnology
$5.75
$0.00(0.00%)
U.S. Market is Open • 15:45

Idorsia Ltd (IDRSF) Stock Overview

Explore Idorsia Ltd’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-5.18
EPS (TTM)$-1.32
ROE0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$4.87
3 Months$6.78
1 Year Target$6.25

IDRSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Idorsia Ltd (IDRSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 91.25, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $6.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.18 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
33.10%
3-Month Change
11.87%
6-Month Change
47.06%
Year-to-Date (YTD) Change
9.52%
1-Year Change
283.33%
3-Year Change
-37.84%
5-Year Change
-78.14%
All-Time (Max) Change
-68.06%

Contact Information

https://www.idorsia.com
41 58 844 10 10
Hegenheimermattweg 91, Allschwil, NaN, 4123

Company Facts

1,100 Employees
IPO DateJul 17, 2017
CountryCH
Actively Trading

Frequently Asked Questions